SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950123-08-006150
Filing Date
2008-05-27
Accepted
2008-05-27 16:47:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D y59411sc13dza.htm SC 13D/A 45147
  Complete submission text file 0000950123-08-006150.txt   47161
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 08861203
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address
Business Address ILEX ONCOLOGY INC 4545 HORIZON HILL BLVD. SAN ANTONIO TX 78229-2263
BUCHALTER JEFFREY H (Filed by) CIK: 0001201040 (see all company filings)

Type: SC 13D/A